Please login to the form below

Not currently logged in
Email:
Password:

Durbin

This page shows the latest Durbin news and features for those working in and with pharma, biotech and healthcare.

News in Brief, May 30, 2007

The Association of American Medical Colleges opposes the proposed change. Senator Richard Durbin (Democrat Illinois) is proposing legislation which would prevent the human services departmentís Centers for Medicare &Medicaid Services from

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Durbin appoints US business development principal Durbin appoints US business development principal

    Specialist medical supplier Durbin has appointed Todd Galles as its business development principal in the US in a permanent capacity. ... Prior to joining Durbin, Galles served as director of business development at C3 Research Associates, business

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Durbin PLC

    Durbin is one of the world’s leading specialist medical suppliers. Established nearly 50 years ago in 1963, we source and distribute pharmaceuticals, medical equipment and consumable supplies to healthcare professionals ... Telephone:44 (0) 20 8869 6500

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics